BEERSE, Belgium, October 25, 2012 /PRNewswire/ --
Janssen-Cilag International announced today that the European Commission (EC) has approved a 100mg/ml oral suspension of PREZISTA® (darunavir), and the use of darunavir co-administered with low dose ritonavir, for the treatment of...
Trending Articles
More Pages to Explore .....